MPM BioVentures 2014 GP LLC, 10% Owner at Harpoon Therapeutics, Inc. (HARP), bought 250,000 shares at $14.00 ($3.5M) on 2019-02-12, disclosed to the SEC on 2019-02-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| HARP | SELL | 2019-02-14 | $21K | — | Filing → |